Cecilie Delphin Amdal

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials

Toxicities in long‐term survivors of head and neck cancer—A multi‐national cross‐sectional analysis

Oral health-related quality of life among long-term head and neck cancer survivors: a multinational study

Long‐term health‐related quality of life in head and neck cancer survivors: A large multinational study

The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View

Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure

Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review

Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale

International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ‐HN43: Phase IV